Poor early response to methotrexate portends inadequate long-term outcomes in patients with moderate-to-severe psoriasis: Evidence from 2 phase 3 clinical trials
Gordon, Kenneth B., Betts, Keith A., Sundaram, Murali, Signorovitch, James E., Li, Junlong, Xie, Meng, Wu, Eric Q., Okun, Martin M.Language:
english
Journal:
Journal of the American Academy of Dermatology
DOI:
10.1016/j.jaad.2017.08.017
Date:
October, 2017
File:
PDF, 312 KB
english, 2017